CA
MIST icon

Cetera Advisors’s Milestone Pharmaceuticals MIST Stock Holding History

Cetera Advisors’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$18.5K Buy
+10,326
New +$16.8K ﹤0.01% 2399

Other funds holding MIST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cetera Advisors's MIST Position: Q1 2024 in Review

Cetera Advisors opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2024: 10,326 shares worth $18.5K. The stake represents ﹤0.01% of the portfolio and ranks #2399 among its holdings.

44 funds tracked by Wall St. Rank hold MIST as of Q1 2024.

  • Cetera Advisors held 10,326 shares of Milestone Pharmaceuticals worth $18.5K as of Q1 2024.
  • Milestone Pharmaceuticals was a new Cetera Advisors position in Q1 2024.
  • Milestone Pharmaceuticals made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2399 holding.
  • 44 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.